Going against the Grain: Aspirin use linked to pancreatic cancer | Science News

Real Science. Real News.

Science News is a nonprofit.

Support us by subscribing now.


Going against the Grain: Aspirin use linked to pancreatic cancer

10:06am, January 7, 2004

In a finding that runs counter to prevailing wisdom, scientists have associated aspirin use with cancer of the pancreas.

Since past studies linked chronic inflammation to various malignancies, the researchers had expected the anti-inflammatory effects of aspirin to suppress pancreatic cancer. Indeed, a smaller study in 2002 found that people taking aspirin had less pancreatic cancer than people not taking aspirin did.

Finding the opposite was "quite a surprise," says Eva S. Schernhammer, an epidemiologist at Harvard Medical School and Brigham and Women's Hospital in Boston, who coauthored the new study. It appears in the Jan. 7 Journal of the National Cancer Institute.

Pancreatic cancer is uncommon but rapidly fatal, mainly because the early stages of the malignancy often go undetected and the pancreas is difficult to examine and treat.

Schernhammer and her colleagues analyzed health information on 88,378 female nurses that was amassed between 1980

This article is only available to Science News subscribers. Already a subscriber? Log in now.
Or subscribe today for full access.

Get Science News headlines by e-mail.

More from Science News

From the Nature Index Paid Content